Use of Mobile Devices to Measure Outcomes in Clinical Research, 2010–2016: A Systematic Literature Review
Open accessThe DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Abstract
Background: The use of mobile devices in clinical research has advanced substantially in recent years due to the rapid pace of technology development. With an overall aim of informing the future use of mobile devices in interventional clinical research to measure primary outcomes, we conducted a systematic review of the use of and clinical outcomes measured by mobile devices (mobile outcomes) in observational and interventional clinical research. Method: We conducted a PubMed search using a range of search terms to retrieve peer-reviewed articles on clinical research published between January 2010 and May 2016 in which mobile devices were used to measure study outcomes. We screened each publication for specific inclusion and exclusion criteria. We then identified and qualitatively summarized the use of mobile outcome assessments in clinical research, including the type and design of the study, therapeutic focus, type of mobile device(s) used, and specific mobile outcomes reported. Results: The search retrieved 2,530 potential articles of interest. After screening, 88 publications remained. Twenty-five percent of the publications (n = 22) described mobile outcomes used in interventional research, and the rest (n = 66) described observational clinical research. Thirteen therapeutic areas were represented. Five categories of mobile devices were identified: (1) inertial sensors, (2) biosensors, (3) pressure sensors and walkways, (4) medication adherence monitors, and (5) location monitors; inertial sensors/accelerometers were most common (reported in 86% of the publications). Among the variety of mobile outcomes, various assessments of physical activity were most common (reported in 74% of the publications). Other mobile outcomes included assessments of sleep, mobility, and pill adherence, as well as biomarkers assessed using a mobile device, including cardiac measures, glucose, gastric reflux, respiratory measures, and intensity of head-related injury. Conclusion: Mobile devices are being widely used in clinical research to assess outcomes, although their use in interventional research to assess therapeutic effectiveness is limited. For mobile devices to be used more frequently in pivotal interventional research – such as trials informing regulatory decision-making – more focus should be placed on: (1) consolidating the evidence supporting the clinical meaningfulness of specific mobile outcomes, and (2) standardizing the use of mobile devices in clinical research to measure specific mobile outcomes (e.g., data capture frequencies, placement of device). To that aim, this manuscript offers a broad overview of the various mobile outcome assessments currently used in observational and interventional research, and categorizes and consolidates this information for researchers interested in using mobile devices to assess outcomes in interventional research.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Strimbu, K., & Tavel, J. A. (2010) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0b013e32833ed177 · Cited by 2,062
Quantitative wearable sensors for objective assessment of Parkinson's disease
Maetzler, W., Domingos, J., Srulijes, K., Ferreira, J. J., & Bloem, B. R. (2013) · Movement Disorders · doi:10.1002/mds.25628 · Cited by 374
Godinho, C., Domingos, J., Cunha, G., Santos, A. T., Fernandes, R. M., Abreu, D., Gonçalves, N., Matthews, H., Isaacs, T., Duffen, J., et al. (2016) · Journal of NeuroEngineering and Rehabilitation · doi:10.1186/s12984-016-0136-7 · Cited by 226
Ginis, P., Nieuwboer, A., Dorfman, M., Ferrari, A., Gazit, E., Canning, C. G., Rocchi, L., Chiari, L., Hausdorff, J. M., & Mirelman, A. (2016) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2015.11.004 · Cited by 225
Objective Assessment of Fall Risk in Parkinson's Disease Using a Body-Fixed Sensor Worn for 3 Days
Weiss, A., Herman, T., Giladi, N., & Hausdorff, J. M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0096675 · Cited by 225
Hou, M. Y., Hurwitz, S., Kavanagh, E., Fortin, J., & Goldberg, A. B. (2010) · Obstetrics & Gynecology · doi:10.1097/aog.0b013e3181eb6b0f · Cited by 176
Wearable sensor-based objective assessment of motor symptoms in Parkinson’s disease
Ossig, C., Antonini, A., Buhmann, C., Classen, J., Csoti, I., Falkenburger, B., Schwarz, M., Winkler, J., & Storch, A. (2016) · Journal of Neural Transmission · doi:10.1007/s00702-015-1439-8 · Cited by 164
Hjorth, M. F., Chaput, J.-P., Michaelsen, K., Astrup, A., Tetens, I., & Sjödin, A. (2013) · BMC Public Health · doi:10.1186/1471-2458-13-808 · Cited by 143
Rondanelli, M., Opizzi, A., Monteferrario, F., Antoniello, N., Manni, R., & Klersy, C. (2011) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2010.03232.x · Cited by 126
Novel Methods and Technologies for 21st-Century Clinical Trials: A Review
Dorsey, E. R., Venuto, C., Venkataraman, V., Harris, D. A., & Kieburtz, K. (2015) · JAMA Neurology · doi:10.1001/jamaneurol.2014.4524 · Cited by 118
Renard, E., Farret, A., Kropff, J., Bruttomesso, D., Messori, M., Place, J., Visentin, R., Calore, R., Toffanin, C., Di Palma, F., et al. (2016) · Diabetes Care · doi:10.2337/dc16-0008 · Cited by 104
Prince, S. A., Blanchard, C. M., Grace, S. L., & Reid, R. D. (2016) · European Journal of Preventive Cardiology · doi:10.1177/2047487315617101 · Cited by 83
An Integrated Multivariable Artificial Pancreas Control System
Turksoy, K., Quinn, L. T., Littlejohn, E., & Cinar, A. (2014) · Journal of Diabetes Science and Technology · doi:10.1177/1932296814524862 · Cited by 77
Klenk, J., Dallmeier, D., Denkinger, M. D., Rapp, K., Koenig, W., Rothenbacher, D., & ActiFE Study Group (2016) · PLOS ONE · doi:10.1371/journal.pone.0153779 · Cited by 63
Hamer, M., Venuraju, S. M., Lahiri, A., Rossi, A., & Steptoe, A. (2012) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.111.236877 · Cited by 50
Kim, J., Nakamura, T., Kikuchi, H., Yoshiuchi, K., Sasaki, T., & Yamamoto, Y. (2015) · IEEE Journal of Biomedical and Health Informatics · doi:10.1109/jbhi.2015.2440764 · Cited by 45
Cited by
Sim, I. (2019) · New England Journal of Medicine · doi:10.1056/nejmra1806949 · Cited by 491
Pratap, A., Neto, E. C., Snyder, P., Stepnowsky, C., Elhadad, N., Grant, D., Mohebbi, M. H., Mooney, S., Suver, C., Wilbanks, J., et al. (2020) · npj Digital Medicine · doi:10.1038/s41746-020-0224-8 · Cited by 410
“The global penetration(9) and high-frequency usage of smartphones (up to 4 h daily(10,11)) offer researchers a potentially costeffective means to recruit a large number of participants into health research across the US (and the world).(12,13) In the last 5 years, investigators have conducted several large-scale studi…”
Digital Twins for Multiple Sclerosis
Voigt, I., Inojosa, H., Dillenseger, A., Haase, R., Akgün, K., & Ziemssen, T. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.669811 · Cited by 272
Tougui, I., Jilbab, A., & Mhamdi, J. E. (2021) · Healthcare Informatics Research · doi:10.4258/hir.2021.27.3.189 · Cited by 199
“189 develop useful tools for the management and assessment of diseases [1].”
MethodDetecting the impact of subject characteristics on machine learning-based diagnostic applications
Chaibub Neto, E., Pratap, A., Perumal, T. M., Tummalacherla, M., Snyder, P., Bot, B. M., Trister, A. D., Friend, S. H., Mangravite, L., & Omberg, L. (2019) · npj Digital Medicine · doi:10.1038/s41746-019-0178-x · Cited by 83
Metadata
- Authors
- Perry, B., Herrington, W., Goldsack, J. C., Grandinetti, C. A., Vasisht, K. P., Landray, M. J., Bataille, L., DiCicco, R. A., Bradley, C., Narayan, A., Papadopoulos, E. J., Sheth, N., Skodacek, K., Stem, K., Strong, T. V., Walton, M. K., & Corneli, A.
- Venue
- Digital Biomarkers
- Publisher
- S. Karger AG
- Published
- 2018-01-31
- Volume
- 2
- Issue
- 1
- Pages
- 11-30
- ISSN
- 2504-110X (ISSN-L)
- OpenAlex
- W2791577102
- Cited by
- 71
- References
- 16
- FWCI
- 2.55
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.